Map the pain, image the nerve, protect proven relief
Stem cell therapy for trigeminal neuralgia in Istanbul, Turkey
Our Istanbul team confirms your diagnosis and protects proven medical and surgical options before discussing any experimental cell approach.
Condition-specific editorial anatomy. Explanatory labels remain in accessible text.
Evidence position
What is known, what is investigational, and what is not demonstrated
Diagnosis-first facial pain care
High-resolution MRI helps assess neurovascular compression and secondary causes, and we interpret it alongside your symptoms.
We won't offer perineural injection as established care
Carbamazepine or oxcarbazepine are our usual first-line medicines when appropriate, with proper monitoring.
Preclinical findings aren't pain control
Results vary between patients and stem cell therapy is not a guaranteed cure — no cell route has established durable pain control for this condition.
Direct answer
What the current evidence says
Facial pain has many causes, so we confirm your diagnosis first — dental disease, post-herpetic neuralgia, multiple sclerosis, and tumors can all mimic trigeminal neuralgia. We keep proven medication and procedural options at the center of your care, because the small human cell-therapy literature does not yet show benefit for this condition. Request your free medical evaluation and we'll walk you through what's proven and what's still investigational.
Clinical map
Start with the diagnosis, stage, and treatment context
We never let an unproven cell option delay your access to established medication and procedural pathways.
Established care comes first
- Medication: We optimize carbamazepine, oxcarbazepine, or specialist alternatives with appropriate lab monitoring.
- Imaging and specialist review: A dedicated cranial nerve MRI protocol and neurologic assessment guide your options.
- Procedural options: For refractory confirmed disease, we discuss microvascular decompression, radiosurgery, or percutaneous procedures with their real benefits and risks.
- 01
Classical trigeminal neuralgia
Brief electric-shock attacks in a trigeminal distribution, often triggered by light touch, sometimes with neurovascular compression.
- 02
Secondary trigeminal neuralgia
Multiple sclerosis, tumor, or another structural cause changes both treatment and urgency.
- 03
Facial-pain mimics
Dental, sinus, TMJ, and post-herpetic pain syndromes each need their own care pathway.
Evidence ledger
Read the actual study, including the result that did not change
Each row keeps product identity, route, endpoint, and limitation together so one trial cannot become a generic treatment claim.
01 Systematic review of cellular therapies for trigeminal neuralgia
Open source- Product
- Several experimental cell types across laboratory models
- Route
- Local or systemic delivery in preclinical studies, with no standardized clinical protocol
- Design
- Systematic review of eight reports, including seven preclinical studies and one incidental clinical case
- Finding
- The review found no controlled human trial of cell therapy for trigeminal neuralgia.
- Limitation
- One incidental clinical case and animal studies cannot establish safety, efficacy, dose, route, or durability in patients.
Product and route
A mechanism is not a clinical outcome
- 01
We won't offer perineural injection as established care
Injecting near a cranial nerve adds anatomic and procedural risk without proven benefit, and we say so directly.
BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.
- 02
Preclinical findings aren't pain control
Animal remyelination or anti-inflammatory results don't translate into fewer attacks for you, and we won't imply otherwise.
BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.
Outcomes before travel
Decide what meaningful change would look like
A baseline and a time point matter more than an isolated testimonial. These measures should be chosen before any intervention.
- 01
Attack frequency and trigger burden
- 02
Pain intensity and pain-free intervals
- 03
Medication dose and side effects
- 04
Facial numbness, corneal sensation, chewing, and hearing
- 05
Daily function and sleep
Specialist review
What a complete Istanbul review needs
Our Istanbul team confirms your diagnosis and protects proven medical and surgical options before discussing any experimental cell approach.
Records and baseline
- Pain distribution, duration, triggers, and sensory symptoms
- Dental assessment and high-resolution MRI when indicated
- Multiple sclerosis, shingles, tumor, and procedure history
- Medication doses, response, and lab monitoring
- The exact plan, target, and evidence we recommend for you
Safety and planning checks
- New facial numbness, weakness, hearing change, or a progressive atypical pattern gets prompt diagnostic review.
- We never ask you to stop anticonvulsant medicines abruptly for travel or a procedure.
- If an invasive option is considered in Istanbul, we arrange an independent neurosurgical comparison first.
Transparent planning
Build the medical plan before the package
A quote should follow record review, product disclosure, route rationale, and a written follow-up plan. This page does not invent a universal price.
- New facial numbness, weakness, hearing change, or a progressive atypical pattern gets prompt diagnostic review.
- We never ask you to stop anticonvulsant medicines abruptly for travel or a procedure.
- If an invasive option is considered in Istanbul, we arrange an independent neurosurgical comparison first.
Questions the plan must answer
- 01
We won't offer perineural injection as established care: Injecting near a cranial nerve adds anatomic and procedural risk without proven benefit, and we say so directly.
- 02
Preclinical findings aren't pain control: Animal remyelination or anti-inflammatory results don't translate into fewer attacks for you, and we won't imply otherwise.
Primary reading
Guidelines, trials, and regulatory context
FAQ
Questions patients ask before an Istanbul review
Request Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.